Imaging inflammation in artery plaques during surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a special dye that makes inflamed areas in artery plaques glow during surgery. It may help doctors see which plaques are dangerous and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe narrowing or bulging of the arteries in your legs or neck (carotid or peripheral artery disease) and are scheduled for surgery.
- You are 18 years or older.
- You are healthy enough to undergo surgery and can give informed consent.
- If you are a woman who can have children, you must have a negative pregnancy test.
- Your kidney function must be normal or only mildly reduced (eGFR ≥ 60).
- You have no allergies to contrast agents or polyethylene glycol (PEG), and no history of severe allergic reactions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies plaque activity in leg arteries using a new imaging method to understand artery disease better. It may help people with peripheral artery disease get more targeted treatment.
This trial looks at specific markers in the blood to better understand unstable plaque in the carotid artery. It may help doctors identify which patients are at higher risk for stroke.
This study uses a heart stress ultrasound test, plus a contrast dye, to look for new blood vessel growth inside carotid plaque (the buildup in neck arteries). It may help doctors better judge the risk of stroke and determine which people need closer care.
This Phase 1 study tests whether a special PET scan can detect a specific inflammation signal (CCR2) in atherosclerosis—fatty plaque buildup in blood vessels. It may help future doctors better see which plaques are more inflamed and potentially more dangerous.
This study uses special ultrasound and MRI scans to look closely at plaque buildup in the neck arteries. The goal is to better understand the plaque, which may help doctors plan safer treatments for people with narrowed arteries.
This trial tests a new contrast agent called ABL-101 that helps MRI scans show inflammation in the fatty buildup (plaque) in the carotid artery. The goal is to better identify dangerous plaque before surgery to remove it, which may help prevent strokes.
Hear when a new Carotid Artery Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.